Regions Financial Corp’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $404K | Buy |
1,906
+202
| +12% | +$39.6K | ﹤0.01% | 665 |
|
|
2026
Q1 | $334K | Hold |
1,704
| – | – | ﹤0.01% | 721 |
|
|
2025
Q4 | $296K | Hold |
1,704
| – | – | ﹤0.01% | 725 |
|
|
2025
Q3 | $325K | Buy |
1,704
+150
| +10% | +$26.6K | ﹤0.01% | 713 |
|
|
2025
Q2 | $279K | Sell |
1,554
-631
| -29% | -$110K | ﹤0.01% | 733 |
|
|
2025
Q1 | $370K | Buy |
2,185
+20
| +0.9% | +$3.29K | ﹤0.01% | 638 |
|
|
2024
Q4 | $327K | Sell |
2,165
-55
| -2% | -$8.55K | ﹤0.01% | 667 |
|
|
2024
Q3 | $345K | Buy |
2,220
+3
| +0.1% | +$448 | ﹤0.01% | 666 |
|
|
2024
Q2 | $303K | Sell |
2,217
-1,068
| -33% | -$146K | ﹤0.01% | 678 |
|
|
2024
Q1 | $437K | Buy |
3,285
+3
| +0.1% | +$389 | ﹤0.01% | 618 |
|
|
2023
Q4 | $453K | Buy |
3,282
+113
| +4% | +$14.9K | ﹤0.01% | 606 |
|
|
2023
Q3 | $386K | Hold |
3,169
| – | – | ﹤0.01% | 612 |
|
|
2023
Q2 | $445K | Sell |
3,169
-835
| -21% | -$115K | ﹤0.01% | 607 |
|
|
2023
Q1 | $567K | Sell |
4,004
-34
| -0.8% | -$4.86K | 0.01% | 570 |
|
|
2022
Q4 | $632K | Buy |
4,038
+34
| +0.8% | +$4.89K | 0.01% | 558 |
|
|
2022
Q3 | $491K | Hold |
4,004
| – | – | 0.01% | 578 |
|
|
2022
Q2 | $533K | Hold |
4,004
| – | – | 0.01% | 580 |
|
|
2022
Q1 | $548K | Hold |
4,004
| – | – | ﹤0.01% | 605 |
|
|
2021
Q4 | $693K | Hold |
4,004
| – | – | 0.01% | 570 |
|
|
2021
Q3 | $582K | Buy |
4,004
+1,000
| +33% | +$146K | 0.01% | 581 |
|
|
2021
Q2 | $397K | Buy |
3,004
+549
| +22% | +$71.9K | ﹤0.01% | 668 |
|
|
2021
Q1 | $315K | Hold |
2,455
| – | – | ﹤0.01% | 699 |
|
|
2020
Q4 | $293K | Sell |
2,455
-3
| -0.1% | -$366 | ﹤0.01% | 680 |
|
|
2020
Q3 | $282K | Hold |
2,458
| – | – | ﹤0.01% | 654 |
|
|
2020
Q2 | $280K | Buy |
+2,458
| New | +$261K | ﹤0.01% | 651 |
|
|
2020
Q1 | – | Sell |
-2,482
| Closed | -$265K | – | 824 |
|
|
2019
Q4 | $265K | Sell |
2,482
-47
| -2% | -$4.9K | ﹤0.01% | 711 |
|
|
2019
Q3 | $270K | Buy |
+2,529
| New | +$260K | ﹤0.01% | 678 |
|
|
2019
Q2 | – | Sell |
-971
| Closed | -$87K | – | 1031 |
|
|
2019
Q1 | $87K | Hold |
971
| – | – | ﹤0.01% | 1019 |
|
|
2018
Q4 | $81K | Sell |
971
-206
| -18% | -$19.3K | ﹤0.01% | 1016 |
|
|
2018
Q3 | $127K | Sell |
1,177
-30
| -2% | -$3.29K | ﹤0.01% | 965 |
|
|
2018
Q2 | $133K | Sell |
1,207
-203
| -14% | -$21.1K | ﹤0.01% | 938 |
|
|
2018
Q1 | $141K | Buy |
1,410
+39
| +3% | +$3.99K | ﹤0.01% | 931 |
|
|
2017
Q4 | $135K | Buy |
+1,371
| New | +$130K | ﹤0.01% | 961 |
|
Other funds holding DGX
EIG
Regions Financial Corp's DGX Position: Q2 2026 in Review
Regions Financial Corp increased its Quest Diagnostics (DGX) stake by 12% in Q2 2026, buying an estimated $39.6K and bringing the position to 1,906 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #665.
Regions Financial Corp first reported a position in DGX in Q4 2017 and has held it in 33 quarters since. The position peaked at $693K in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Regions Financial Corp held 1,906 shares of Quest Diagnostics worth $404K as of Q2 2026.
- Regions Financial Corp bought 202 Quest Diagnostics shares in Q2 2026, an estimated $39.6K.
- Quest Diagnostics made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #665 holding.
- Regions Financial Corp first reported a position in Quest Diagnostics in Q4 2017 and has held it in 33 quarters since.
- Regions Financial Corp's Quest Diagnostics position peaked at $693K in Q4 2021.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.